Differential effects of COX inhibitors against β-amyloid-induced neurotoxicity in human neuroblastoma cells

Neurochemistry International

Volumn 47, Issue 8, 2005, Pages 589-596

  Ferrera, P ^a   Arias, C ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amyloid protein; Arachidonic acid; COX 2; Human neuroblastoma; Indomethacin; Neuroprotection; Neurotoxicity

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; LIPOXYGENASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; INDOMETHACIN; MEMBRANE PROTEINS; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; NITROBENZENES; PEPTIDE FRAGMENTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 26444548179     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.06.012     Document Type: Article

References (36)

1. P.S. Aisen, K.A. Schafer, M. Grundman, E. Pfeiffer, M. Sano, K.L. Davis, M.R. Farlow, S. Jin, R.G. Thomas, and L.J. Thal Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial JAMA 289 2003 2819 2826
2. 2 pathway in production of reactive oxygen species in Alzheimer's disease Neurochem. Res. 28 2003 319 326
3. M. Asanuma, S. Nishibayashi-Asanuma, I. Miyazaki, M. Kohno, and N. Ogawa Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals J. Neurochem. 76 2001 1895 1904
4. 1-42 Neuroreport 14 2003 2099 2103
5. B.M. Bayer, and M.A. Beaven Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle Biochem. Pharmacol. 28 1979 441 443
6. C.W. Cotman, C.J. Pike, and A. Conpani β-Amyloid neurotoxicity: a discussion on in vitro findings Neurobiol. Aging 13 1992 587 590
7. B. Cryer, and M. Feldman Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs Am. J. Med. 104 1998 413 421
8. J. Domin, T. Higgins, and E. Rozengurt Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid J. Biol. Chem. 269 1994 8260 8267
9. Z.Y. Du, and X.Y. Li Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro Int. J. Immunopharmacol. 21 1999 219 225
10. Y. Eli, F. Przedecki, G. Levin, N. Kariv, and A. Raz Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo Biochem. Pharmacol. 61 2001 565 571
11. M. Encinas, M. Iglesias, Y. Liu, H. Wang, A. Muhaisen, V. Cena, C. Gallego, and J.X. Comella Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells J. Neurochem. 75 2000 991 1003
12. 1-42 toxicity in PC12 cells Mol. Psych. 1 1996 398 403
13. 2 and its role in brain tissue J. Neurochem. 69 1997 889 901
14. 2 synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-κB J. Neurochem. 75 2000 2020 2028
15. Y. Goodman, M.R. Steiner, S.M. Steiner, and M.P. Mattson Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation Brain Res. 654 1994 171 176
16. K. Hensley, J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, J.F. Wu, R.A. Floyd, and D.A. Butterfield A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 91 1994 3270 3274
17. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat. Med. 4 1998 97 100
18. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice Science 274 1996 99 102
19. H. Kwon, S. Park, S. Lee, D.K. Lee, and C.H. Yang Determination of binding constant of transcription factor AP-1 and DNA. Application of inhibitors Eur. J. Biochem. 268 2001 565 572
20. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, and S.A. Kliewer peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 272 1997 3406 3410
21. 2 by amyloid β-peptides in vitro Biochemistry 35 1996 9407 9414
22. W.J. Lukiw, and N.G. Bazan Neuroinflammatory signaling upregulation in Azheimer's disease Neurochem. Res. 25 2000 1173 1184
23. M.P. Mattson, and Y. Goodman Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium Brain Res. 676 1995 219 224
24. T. Mossman Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity J. Immunol. Methods 65 1983 55 63
25. D. Paris, T. Town, T. Mori, T.A. Parker, J. Humphrey, and M. Mullan Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway Neurobiol. Aging 21 2000 183 197
26. M. Pavani, E. Fones, D. Oksenberg, M. Garcia, C. Hernandez, G. Cordano, S. Munoz, J. Mancilla, A. Guerrero, and J. Ferreira Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid Biochem. Pharmacol. 48 1994 1935 1942
27. S.A. Reines, G.A. Block, J.C. Morris, G. Liu, M.L. Nessly, C.R. Lines, B.A. Norman, C.C. Baranak Rofecoxib Protocol 091 Study Group Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study Neurology 62 2004 66 71
28. C.P. Reynolds, J.L. Biedler, B.A. Spengler, D.A. Reynolds, R.A. Ross, E.P. Frenkel, and R.G. Smith Characterization of human neuroblastoma cell lines established before and after therapy J. Natl. Cancer Inst. 76 1986 375 387
29. J. Rogers, L.C. Kirby, S.R. Hempelman, D.L. Berry, P.L. McGeer, A.W. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, P. Willson, and F. Kogan Clinical trial of indomethacin in Alzheimer's disease Neurology 43 1993 1609 1611
30. H. Salari, P. Braquet, and P. Borgeat Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets Prostaglandins Leukot. Med. 13 1984 53 60
31. D.G. Tang, and K.V. Honn Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival J. Cell Physiol. 172 1997 155 170
32. M.E. Turini, and R.N. DuBois Cyclooxygenase-2: a therapeutic target Ann. Rev. Med. 53 2002 35 57
33. D.M. Walsh, I. Klyubin, J.V. Fadeeva, M.J. Rowan, and D.J. Selkoe Amyloid-β oligomers: their production, toxicity and therapeutic inhibition Biochem. Soc. Trans. 30 2002 552 557
34. β42 independently of cyclooxygenase activity Nature 414 2001 212 216
35. M. West, M. Mhatre, A. Ceballos, R.A. Floyd, P. Grammas, S.P. Gabbita, L. Hamdheydari, T. Mai, S. Mou, Q.N. Pye, C. Stewart, S. West, K.S. Williamson, F. Zemlan, and K. Hensley The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor α activation of microglia and extends survival of G93A-SOD1 transgenic mice J. Neurochem. 91 2004 133 143
36. K. Yamagata, K.I. Andreasson, W.E. Kaufmann, C.A. Barnes, and P.F. Worley Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids Neuron 11 1993 371 386